BACKGROUND & AIMS: In several rat infection experiments, we have shown that dietary calcium inhibits intestinal colonization and translocation of invasive salmonella. The aim of the present study was to find out whether calcium is also protective against enterotoxigenic Escherichia coli (ETEC) infection. This was first tested in our rat model and subsequently verified in a human infection study. METHODS:Rats were fed a purified diet with either a low or a high amount of calcium phosphate and orally infected with ETEC. In addition, a parallel, double-blind, placebo-controlled intervention study of 3 weeks was performed with 32 healthy men. Subjects largely maintained their habitual diet and consumed either regular milk products (calcium supply, 1100 mg/day) or placebo milk products (calcium supply, 60 mg/day). On day 10, subjects ingested a live but attenuated ETEC strain (strain E1392/75-2A), able to induce mild although short-lived symptoms. Primary outcomes studied were infection-induced diarrhea (total fecal output and relative fecal dry weight) and fecal mucin excretion. RESULTS: In humans, ETEC induced diarrhea in both groups, in that total fecal output doubled and mean relative fecal dry weight dropped from 25% to 20%. Additionally, fecal mucin excretion was increased in both groups. All these fecal parameters were completely normalized in the calcium group on the second infection day, in contrast to the placebo group, which recovered on the third infection day. Likewise, supplemental calcium inhibited ETEC colonization and diarrhea in rats. CONCLUSIONS:Calcium in milk products improves human resistance to ETEC infection as it inhibits infectious diarrhea.
RCT Entities:
BACKGROUND & AIMS: In several rat infection experiments, we have shown that dietary calcium inhibits intestinal colonization and translocation of invasive salmonella. The aim of the present study was to find out whether calcium is also protective against enterotoxigenic Escherichia coli (ETEC) infection. This was first tested in our rat model and subsequently verified in a human infection study. METHODS:Rats were fed a purified diet with either a low or a high amount of calcium phosphate and orally infected with ETEC. In addition, a parallel, double-blind, placebo-controlled intervention study of 3 weeks was performed with 32 healthy men. Subjects largely maintained their habitual diet and consumed either regular milk products (calcium supply, 1100 mg/day) or placebo milk products (calcium supply, 60 mg/day). On day 10, subjects ingested a live but attenuated ETEC strain (strain E1392/75-2A), able to induce mild although short-lived symptoms. Primary outcomes studied were infection-induced diarrhea (total fecal output and relative fecal dry weight) and fecal mucin excretion. RESULTS: In humans, ETEC induced diarrhea in both groups, in that total fecal output doubled and mean relative fecal dry weight dropped from 25% to 20%. Additionally, fecal mucin excretion was increased in both groups. All these fecal parameters were completely normalized in the calcium group on the second infection day, in contrast to the placebo group, which recovered on the third infection day. Likewise, supplemental calcium inhibited ETEC colonization and diarrhea in rats. CONCLUSIONS:Calcium in milk products improves human resistance to ETEC infection as it inhibits infectious diarrhea.
Authors: S J M Ten Bruggencate; S A Girard; E G M Floris-Vollenbroek; R Bhardwaj; T A Tompkins Journal: Eur J Clin Nutr Date: 2014-11-05 Impact factor: 4.016
Authors: Sam X Cheng; Yaíma L Lightfoot; Tao Yang; Mojgan Zadeh; Lieqi Tang; Bikash Sahay; Gary P Wang; Jennifer L Owen; Mansour Mohamadzadeh Journal: FEBS Lett Date: 2014-05-17 Impact factor: 4.124
Authors: John Geibel; Kumudesh Sritharan; Rainer Geibel; Peter Geibel; J Scott Persing; Achim Seeger; Torsten K Roepke; Markus Deichstetter; Christian Prinz; Sam X Cheng; David Martin; Steven C Hebert Journal: Proc Natl Acad Sci U S A Date: 2006-06-07 Impact factor: 11.205
Authors: Sam X Cheng; Harrison X Bai; Regino Gonzalez-Peralta; Pramod K Mistry; Fred S Gorelick Journal: J Pediatr Gastroenterol Nutr Date: 2013-06 Impact factor: 2.839
Authors: L M P Loonen; E H Stolte; M T J Jaklofsky; M Meijerink; J Dekker; P van Baarlen; J M Wells Journal: Mucosal Immunol Date: 2013-12-18 Impact factor: 7.313
Authors: Baiyu Yang; Roberd M Bostick; Hao Quang Tran; Andrew T Gewirtz; Peter T Campbell; Veronika Fedirko Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-12-16 Impact factor: 4.254